Permanent Fillers

Serra, M.; Gonçalves, Leonardo Zacharias

doi:10.1007/978-3-319-20253-2_30-1

Cited by 1 publication

(2 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1 The most common types of PFs are silicones, polyalkylimides, polyacrylamides, and polymethyl methacrylates. 4 The incidence of complications associated with soft-tissue augmentation using PFs has been demonstrated in the literature. 5,9 In Saudi Arabia, there is a knowledge gap in estimating the incidence of complications related to PFs.…”

Section: Discussionmentioning

confidence: 99%

“…3 The most commonly used PFs are silicone-based products, polyalkylimide, polyacrylamide, and polymethyl methacrylate. 4 Although these injections are safe and simple and have become an attractive alternative to cosmetic procedures requiring incision, such as fat grafting or facelift procedures, 5 their widespread use globally leads to increased complications. 6 The documented adverse events have increased physician and patient awareness of one of the most severe problems associated with filler injections, such as intravascular complications.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Complications following Permanent Filler Injection: A Prospective Cohort Study and Protocol of Management

Mortada

Saud

Alaithan

et al. 2022

Plastic and Reconstructive Surgery - Global Open

View full text Add to dashboard Cite

Introduction: Permanent filler (PF) substances are increasingly utilized in aesthetic procedures. Concurrently, complications related to fillers have also risen. This study aims to determine the rate of complications secondary to PF injections and develop a therapeutic approach for treating such complications. Methods: This cohort study was conducted by distributing a checklist form among all patients aged 18 years or older who arrived for a new cosmetic consultation between 2015 and 2019. The primary outcome was the occurrence of complications, which are defined as symptoms induced by the PF. The demographics, type of PF, injection site, the time for the complication to occur, and signs and symptoms were recorded and followed up. Results: In this study, 325 out of 503 (64.61%) patients presented with PF-related complications. About 92.8% were women. All patients with PF-related complications presented with a lump (n = 325, 100%). In regard to the anatomical area of injection, the most common areas were the cheeks (66.6%). The time it took for the complication to occur most commonly ranged from 1–5 years (39.2%, P < 0.001). Complications were significantly higher among patients who received the injection in a nonmedical facility (P < 0.0002). Seventy-seven cases (15.3%, P < 0.0001) underwent PF removal. Conclusions: PF-related complications in the body exhibit a wide range of onset and adverse events. The best method to prevent complications caused by permanent filling materials is to avoid them altogether. When it comes to permanent filling agents, we suggest extreme caution.

show abstract

Section: Discussionmentioning

confidence: 99%